Psyence Group Inc (PSYG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 26 | 27 | 27 | 12 | 15 |
| Accounts receivable | -79 | 46 | -16 | -19 | -94 |
| Accounts payable and accrued liabilities | 2,280 | 33 | -5 | 144 | 0 |
| Other Working Capital | 1,566 | 121 | -28 | 161 | -132 |
| Other Operating Activity | -5,273 | -589 | -901 | -1,176 | -877 |
| Operating Cash Flow | $-1,479 | $-361 | $-923 | $-878 | $-1,088 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 904 | -902 | 8 | -275 | -42 |
| Other Investing Activity | 4 | -48 | -101 | -20 | -28 |
| Investing Cash Flow | $908 | $-950 | $-93 | $-295 | $-70 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | N/A | N/A | N/A | 1,023 |
| Debt Repayment | -2 | 0 | -1 | -1 | -1 |
| Common Stock Issued | 1,123 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -34 | 1,875 | 0 | 0 | 0 |
| Financing Cash Flow | $1,087 | $1,874 | $-1 | $-1 | $1,022 |
| Beginning Cash Position | 1,867 | 1,304 | 2,321 | 3,495 | 3,630 |
| End Cash Position | 2,383 | 1,867 | 1,304 | 2,321 | 3,495 |
| Net Cash Flow | $516 | $563 | $-1,017 | $-1,174 | $-136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,479 | -361 | -923 | -878 | -1,088 |
| Capital Expenditure | N/A | -902 | N/A | -275 | -42 |
| Free Cash Flow | -1,479 | -1,263 | -923 | -1,152 | -1,130 |